Posts

Showing posts with the label Adrenal Crisis

Adrenal Crisis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035

Adrenal Crisis Market Outlook Thelansis’s “Adrenal Crisis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Adrenal Crisis treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Key business questions answered: How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)? How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments? What is the 10-year market outlook for sales and patient share? Which events will have the greatest impact on the market’s trajectory? What insights do in...

Adrenal Crisis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Adrenal Crisis Market Outlook Thelansis’s “Adrenal Crisis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Adrenal Crisis treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Adrenal Crisis Overview Adrenal crisis (Addisonian crisis/acute adrenal insufficiency/bronze Addison disease) as a profound impairment of general health and at least two of the following conditions hypotension (systolic blood pressure 100mmHg), severe fatigue, vomiting or nausea, hyperkalemia, hypoglycemia, and hyponatremia triggering parenteral glucocorticoid administration. The risk factor associated with the adrenal crisis is diabetes insipidus, diabetes mel...

Adrenal Crisis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Image
 Adrenal crisis (Addisonian crisis/acute adrenal insufficiency/bronze Addison disease) as a profound impairment of general health and at least two of the following conditions hypotension (systolic blood pressure 100mmHg), severe fatigue, vomiting or nausea, hyperkalemia, hypoglycemia, and hyponatremia triggering parenteral glucocorticoid administration. The risk factor associated with the adrenal crisis is diabetes insipidus, diabetes mellitus (type 1 and type 2), hypogonadism, adrenal hemorrhage, pregnancy, and polyglandular autoimmune syndrome 1 and 2. An adrenal crisis occurs when there is adrenal insufficiency, either primary or secondary. Primary adrenal crisis is characterized by high ACTH from the destruction of the adrenal gland and low cortisol. Secondary adrenal insufficiency is characterized by low cortisol and normal ACTH caused by decreased ACTH secretion from the pituitary. The tertiary cause includes the disruption of the hypothalamus, which affects the release of CR...